Trade news

Meiji Holdings and dsm-firmenich to improve dairy sustainability with methane-reducing feed additive Bovaer®


Kaiseraugst (Switzerland), Maastricht (Netherlands), May 8, 2024

dsm-firmenich, innovators in health, nutrition and beauty, and Meiji Holdings Co., Ltd. ("Meiji HD"), a leading Asian dairy company based in Japan, have signed a Memorandum of Understanding to enhance the sustainability of Japanese dairy farming through the implementation of Bovaer®. This is the first such agreement in Asia.

Bovaer® is the most extensively studied and scientifically proven solution to the challenge of lowering livestock’s methane emissions. In the dairy sector, methane is the most common and powerful greenhouse gas and is mainly generated in the digestive tracts of cows, released when the animals burp. Through the implementation of Bovaer®, methane emissions can be reduced by approximately 30% for dairy, and 45% for beef feedlot cattle.

In 2021, Japan joined the Global Methane Pledge, aiming at a 30% reduction of absolute methane emissions by 2030. Within Japan, over 80% of methane emissions are attributable to the agricultural sector (e.g. rice and cattle). Providing a tool to reduce emissions from over 1 million dairy cows, and over 3 million beef cattle is therefore an important lever to achieve this ambition.

“We are excited to expand the use of Bovaer® into Asia. I’m looking forward to working with Meiji HD to explore how to implement Bovaer® in the Japanese dairy sector and particularly in the Meiji HD supply chain. Preparation works will start now, while we await local market authorization,” said Mark van Nieuwland, Vice President Bovaer® at dsm-firmenich.

Bovaer® is already commercially available in 58 countries including the EU, UK, Canada, Mexico, Australia, most of Latin America, and select other markets. Authorities are currently reviewing an application for registration in Japan.


For more information, please contact:

dsm-firmenich investor relations enquiries:

dsm-firmenich media enquiries:


About dsm-firmenich:

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss-Dutch company, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people.

About Meiji Holdings

Meiji Holdings Co., Ltd. consists of Meiji Co., Ltd. which runs the Food business, and Meiji Seika Pharma Co., Ltd. and KM Biologics Co., Ltd. which run the Pharmaceutical business. Our mission is to widen the world of “Tastiness and Enjoyment” and to meet all expectations regarding “Health and Reassurance” by providing a wide range of products that are essential in people’s lives, such as dairy products, confectioneries, nutritional products, and pharmaceuticals.


This press release does not constitute or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

This press release may contain forward-looking statements with respect to dsm-firmenich’s future. Such statements are based on current expectations, estimates and projections of dsm-firmenich and information currently available to the company. dsm-firmenich cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. dsm-firmenich has no obligation to update the statements contained in this press release, unless required by law. The English language version of this press release prevails over other language versions.